Solventum sells purification and filtration business to Thermo Fisher for $4.1B

Solventum Corp

Thermo Fisher to acquire Solventum's purification and filtration business for $4.1B cash, subject to customary adjustments.
Closing expected by end of 2025; conditioned on HSR, other antitrust approvals, and no Material Adverse Effect.
No financing condition for Thermo Fisher; Solventum grants 3-year non-compete and 2-year non-solicit post-close.
Solventum indemnifies Thermo Fisher for pre-closing liabilities and breaches of reps; 3M must confirm tax opinion.
Termination date November 25, 2025, subject to two 3-month extensions if regulatory conditions are unmet.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.